Skip to content
Search resources Open menu

Alcohol Blackout

Benzodiazepines, Alcohol, and Memory

Published

Snap Shot

  • The question: How do benzodiazepines affect memory, how do their effects combine with alcohol’s, and what does that mean when a complainant, an accused person, or a witness took one of these drugs and drank?
  • What the research shows: Benzodiazepines such as diazepam, alprazolam, lorazepam, clonazepam, and triazolam produce anterograde amnesia, a reduced ability to form new long-term memories, that increases with dose and is not fully explained by sedation. They act on the same GABA-A receptor system through which alcohol impairs memory. Studies of alcohol and benzodiazepines together show greater sedation and, in some studies, greater memory impairment than either substance alone at the doses tested; findings differ (Aitken et al., 2023, found no clear additive cognitive effect at a peak BAC near 0.03), and the combination is a recognized factor in fatal poisonings.
  • What it does not show: Controlled studies of the combination have used low to moderate doses and laboratory tasks; none has measured blackouts at the high BACs common in criminal cases. The research cannot show whether a particular person who took a benzodiazepine and drank was in a blackout, how impaired the person was, or whether the person could consent.
  • The law: Incapacity may result from any drug or intoxicant (Art. 120(b)(3)(A), UCMJ; A.R.S. § 13-1401(A)(7)(b)); covert administration is addressed separately (Art. 120(a)(5); 18 U.S.C. § 2241(b)(2)), and Arizona adds three years to the sentencing range only for covert use of flunitrazepam, GHB, or ketamine (A.R.S. § 13-1406(B)). Abuse of prescribed medications is not a defense in Arizona (A.R.S. § 13-503).
  • Issues for each side: Either side may explain that a benzodiazepine taken with alcohol can impair memory more than the alcohol alone; neither side can infer how the drug was obtained, the dose, or the degree of impairment from a prescription or a toxicology result.

Benzodiazepines are among the most commonly prescribed psychiatric medications, used for anxiety, panic, insomnia, seizures, and alcohol withdrawal. In 2008, about 5.2% of U.S. adults filled a benzodiazepine prescription, use rose with age, and use was nearly twice as common among women as among men (Olfson et al., 2015). Many people who take them also drink. Benzodiazepines also appear in toxicology results in cases of suspected drug-facilitated sexual assault, sometimes from prescribed use and sometimes from use the person did not report or did not know about.

This paper explains how benzodiazepines affect memory, the shared brain mechanism with alcohol, what controlled studies show about the combination, and where these drugs appear in forensic cases. It then describes the limits of the evidence and the governing law. The broader range of medications that add to alcohol’s effects is addressed in Medications That Add to Alcohol’s Effects, and toxicology testing in Drug-Facilitated Sexual Assault: Toxicology, Detection Limits, and What the Results Can Show.

How Benzodiazepines Affect Memory

Benzodiazepines produce anterograde amnesia: they impair memory for information encountered after the drug takes effect, and the amount of amnesia depends on dose and on differences in how long each drug acts (Roth et al., 1984). Reviews of laboratory research describe the effect as one of the most consistent cognitive effects of these drugs (Ghoneim & Mewaldt, 1990; Curran, 1991). Memory is most impaired when information is encountered near the drug’s peak concentration in the blood, and although benzodiazepines also increase sedation and reduce attention, those effects do not fully account for the memory deficits (Buffett-Jerrott & Stewart, 2002). Whether the amnesic effects can be fully separated from sedation has been debated (Curran, 1991). An early account attributed part of the long-term memory loss to rapid sleep onset after a bedtime dose, which interrupts consolidation (Roth et al., 1984); that explanation is most relevant to sleeping pills taken at night.

A direct comparison helps place benzodiazepines beside alcohol. In a placebo-controlled study of 20 social drinkers, triazolam and alcohol were given at doses that produced comparable psychomotor impairment; triazolam was more likely to impair episodic memory and divided attention, while only alcohol impaired some semantic memory and symbol-substitution accuracy. Both drugs impaired participants’ awareness of their own performance, though in the direction of overestimating their impairment (Kleykamp et al., 2010). The drugs overlap in their effects but are not interchangeable.

A Shared Mechanism With Alcohol

Benzodiazepines enhance the action of GABA, the brain’s main inhibitory messenger, at GABA-A receptors, and alcohol also acts in part through these receptors. In a rat study, both alcohol and diazepam produced dose-dependent increases in spatial working memory errors without impairing learning within a day, consistent with a shared GABA-A contribution to their memory effects (White et al., 1997); as animal research, it shows a mechanism, not human behavior. Human evidence points in the same direction. In volunteers with a mean breath alcohol concentration of about 0.15 g/dL, pretreatment with a drug that selectively reduces activity at one GABA-A receptor subtype, the alpha5 subtype, which is concentrated in the hippocampus, almost completely blocked alcohol’s marked impairment of word-list learning without changing how intoxicated participants felt (Nutt et al., 2007). The Hippocampus and Memory Formation During a Blackout explains why that region matters.

What Happens When They Are Combined

Older controlled studies found little added effect at low doses, but later work found additive or greater impairment when diazepam and alcohol were combined, with larger effects at higher doses; alcohol also raised peak diazepam levels in some studies, while alprazolam and alcohol were reported to be additive (Garriott & Manno, 2008). Acute drinking generally slows the metabolism of benzodiazepines, while chronic heavy drinking can speed it, and the combination, especially with triazolam, remains a recurring factor in fatal poisonings (Tanaka, 2002).

More recent controlled studies used modest alcohol doses. In a double-blind crossover study of 20 healthy adults (60% women), a 1 mg dose of alprazolam impaired reaction time, vigilance, and several working memory tasks, with effects greatest about 100 minutes after dosing; a low alcohol dose that produced a peak BAC of about 0.03 had no significant cognitive effect, and an additive cognitive effect of the combination was not evident, although sedation was heightened (Aitken et al., 2023). In a placebo-controlled study of 24 volunteers, the usual advantage in recalling common over uncommon words disappeared when lorazepam and alcohol were given together (Soo-ampon et al., 2004). These studies show that the combination impairs memory, but they used doses far below those typical of heavy drinking, and studies giving benzodiazepines with alcohol at BACs where blackouts are common would raise obvious safety concerns; the research has not identified how the combination changes blackout risk at such levels.

Current labels reflect the clinical concern. The label for alprazolam advises patients to avoid alcohol and other depressants, lists amnesia and impaired memory among effects of misuse, notes that misuse commonly involves alcohol and other substances and that deaths are more often associated with such combinations, and carries a boxed warning about combined use with opioids (Viatris Specialty, 2024). In an interview study of 136 heavy-drinking young adults, most en bloc episodes, and few fragmentary episodes, involved illicit substance use as well as alcohol (Hartzler & Fromme, 2003b); that is consistent with, though it does not isolate, a contribution from other drugs, and it does not show that sedatives were involved.

Hypothetical Example. Consider a hypothetical adult who takes a prescribed dose of a benzodiazepine for anxiety in the late afternoon and drinks several glasses of wine at a dinner that evening, then later recalls only fragments of the night. The research supports the general statement that the combination can impair the formation of new memories more than either the drug at that dose or the alcohol alone would, especially if the drinking occurred near the drug’s peak. It does not show whether the person was in a blackout during any particular period, how the person appeared to others, or whether the person could make or communicate decisions. Those questions depend on the timing, the dose, the amount of alcohol, the person’s tolerance, and the accounts of others, and the same analysis applies whether the person is a complainant or an accused.

Benzodiazepines in Forensic Cases

Benzodiazepines appear regularly in toxicology series from suspected drug-facilitated assaults. In 1,000 suspected U.S. cases, clonazepam was found in 7.6% (Fiorentin & Logan, 2019), and in a 19-year French national survey, benzodiazepines and related sleep drugs such as zolpidem accounted for 55% of substances in cases classified as proven covert administration (Djezzar et al., 2023). Many detections, however, may reflect prescribed or voluntary use, which is why a medication history is essential to interpretation. Flunitrazepam (Rohypnol), the benzodiazepine most associated in public discussion with drink-spiking, became a focus of U.S. criminal investigations in the 1990s (Saum & Inciardi, 1997) but is excluded from the U.S. urine testing standard because of its limited availability in the United States (AAFS Standards Board, 2021). Designer benzodiazepines, potent, often short-lived, and constantly changing, challenge standard testing panels (Pérez Orts et al., 2023). Detection windows, specimens, and what positive and negative results can show are addressed in the Drug-Facilitated Sexual Assault paper.

Limits of the Evidence

The memory research on benzodiazepines comes mostly from healthy volunteers given single doses and tested with word lists and computer tasks; much of the foundational work dates from the 1980s and 1990s. Combination studies used low to moderate alcohol doses, so they say little about the high BACs common in criminal cases, and none measured blackouts directly. Regular users develop tolerance to some effects, which laboratory studies of single doses do not capture. The shared-mechanism evidence includes animal research and one human study of a receptor-selective drug. Sex was seldom analyzed: the combination studies enrolled both sexes without reporting sex differences in their abstracts, while prescription data show that women use benzodiazepines about twice as often as men (Olfson et al., 2015). Group research cannot establish what a particular person took, when, how much, or how it affected that person’s memory or capacity.

Questions to Ask About This Research

When Roth et al. (1984) or another review is cited to show that a benzodiazepine caused a memory gap, counsel can ask whether the dose, the drug’s duration of action, and the timing of the events match the research, and whether the person was asleep or awake during the period in question. When Aitken et al. (2023) is cited to show the combination has no additive effect, counsel can ask what BAC was reached: about 0.03. When Nutt et al. (2007) or White et al. (1997) is cited, counsel can ask whether a mechanism study, one of them in rats, bears on a particular person’s night. When a toxicology result is offered, counsel can ask whether a prescription or medication history explains it (Fiorentin & Logan, 2019). These questions are explained in “Reading Research Claims: A Guide for Attorneys” on this site.

Benzodiazepines and the Law

Federal and Military Standards

Under Article 120(b)(3)(A), UCMJ, sexual assault includes a sexual act on a person incapable of consenting due to impairment by any drug, intoxicant, or other similar substance, when that condition is known or reasonably should be known by the accused. Article 120(a)(5) and 18 U.S.C. § 2241(b)(2) address the separate situation in which the accused administers a drug or intoxicant by force or threat, or without the person’s knowledge or consent (permission, in the federal statute), substantially impairing the person’s ability to appraise or control conduct; the Drug-Facilitated Sexual Assault paper discusses those provisions and the confrontation rules for laboratory evidence. Expert testimony on benzodiazepine and alcohol effects is governed by Federal and Military Rule of Evidence 702 (the federal rule amended December 1, 2023; the amendment took effect in the military rule in 2025, Joint Service Committee on Military Justice, 2025, and practitioners should confirm current text), Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993), Kumho Tire Co. v. Carmichael (1999), and United States v. Houser (1993).

For an accused, voluntary intoxication is not a defense, though it may be considered on actual knowledge, specific intent, willfulness, or premeditation (R.C.M. 916(l)(2)). Military courts recognize involuntary intoxication in narrow circumstances. In United States v. MacDonald (2014), the Court of Appeals for the Armed Forces described involuntary intoxication as an affirmative defense that the accused must show by clear and convincing evidence and held that the military judge must instruct on it when the evidence reasonably raises it. The Military Judges’ Benchbook (DA Pam 27-9, 2025) has no separate involuntary-intoxication instruction; trial judges have adapted the lack-of-mental-responsibility instructions (Instructions 6-4 and 6-7), under which the members first decide whether the elements are proved beyond a reasonable doubt and only then whether the accused has proved the defense by clear and convincing evidence (see United States v. Rice, 2021, describing that procedure). In United States v. Hensler (1996), which involved alcohol combined with prescription medications, the court held that the defense was raised for the first episode but not for five later episodes, because the accused was on notice that she reacted inappropriately to alcohol.

Arizona

Sexual assault “without consent” includes a victim incapable of consent by reason of drugs, alcohol, sleep, or similar impairment, where the condition is known or should reasonably have been known to the defendant (A.R.S. § 13-1401(A)(7)(b)). If a sexual assault involved the intentional or knowing administration of flunitrazepam, gamma hydroxy butyrate, or ketamine hydrochloride without the victim’s knowledge, the presumptive, minimum, and maximum sentences increase by three years (A.R.S. § 13-1406(B)); other benzodiazepines are not listed, and their covert administration is addressed through the general “without consent” definitions. Temporary intoxication from voluntary use of alcohol or other psychoactive substances, or from abuse of prescribed medications, is not a defense for any criminal act or requisite state of mind (A.R.S. § 13-503), while intoxication from the non-abusive use of a prescribed medication may be considered on the required mental state (State v. McKeon, 2002; RAJI (Criminal) Standard 39). Arizona Rule of Evidence 702, amended effective January 1, 2024 (Ariz. Sup. Ct. Order R-23-0004), governs expert testimony, and experts may not opine on a particular witness’s truthfulness (State v. Lindsey, 1986, 149 Ariz. at 475).

Special Issues in Legal Practice

The principles described above apply with equal force to every party in a legal proceeding. The science operates the same way regardless of who is asking the questions, and the research summarized here does not by itself favor either side. What differs between the parties is not the science but the vantage point — the particular places where these issues tend to surface, and the particular errors each party is best positioned to guard against. The two summaries below identify those recurring issues. They are offered for orientation, not as litigation strategy; in every case the controlling question is what the evidence in that case will, and will not, support, and the expert’s role is to inform the trier of fact rather than to advocate for either side.

Special Issues for Prosecutors

The research supports several propositions prosecutors can legitimately present. In laboratory studies, benzodiazepines consistently impair the formation of new memories, act on the same receptor system as alcohol, and show greater sedation, and in some studies greater memory impairment, when combined with alcohol at the doses tested; no study has measured blackout risk at the higher BACs common in cases. A gap after a benzodiazepine with alcohol is consistent with the pharmacology for any person, a complainant or an accused, and does not by itself show what occurred or that an account is untrue. Incapacity may result from any drug, including a lawfully prescribed one. Prompt collection of specimens and a medication history give the best chance of interpreting a result.

The research also counsels caution. A benzodiazepine in a toxicology report does not show who gave it, when, or whether it was taken knowingly, and many detections in case series reflect voluntary or prescribed use (the figures cited, 7.6% clonazepam in 1,000 suspected U.S. cases and 55% of substances in proven covert cases, are samples of different kinds and do not show a proportion for any case). The combination studies used low alcohol doses and did not measure blackouts, so testimony about the size of the combined effect at a particular BAC goes beyond the evidence. The same pharmacology bears on an accused who took such a drug.

Special Issues for Defense

The research supports several propositions defense counsel can legitimately present. A memory gap after a benzodiazepine with alcohol is consistent with the pharmacology for any person, a complainant or an accused, and by itself neither shows what occurred nor that an account is untrue. In Arizona, intoxication from non-abusive prescribed use may be considered on mental state, while military law recognizes involuntary intoxication in narrow circumstances. It is legitimate to ask whether a positive result is explained by a complainant’s or witness’s own prescription, and whether a study’s doses and tasks resemble the facts.

The research also counsels caution about the limits that apply to the defense. Memory loss from a benzodiazepine-alcohol combination does not show that conduct was involuntary or intent absent; Arizona excludes abuse of prescribed medications from any defense, and in military practice an accused who drank while on notice of an inappropriate reaction to alcohol has not been able to raise involuntary intoxication. A complainant’s prescribed benzodiazepine use is not evidence that an account is false, and a negative test does not show that no drug was given.

This paper is for educational purposes only and is not legal advice. The author is a psychologist, not an attorney; summaries of law are general and must be verified against current authority or with a licensed attorney.

References

AAFS Standards Board. (2021). Standard for the analytical scope and sensitivity of forensic toxicological testing of urine in drug-facilitated crime investigations (ANSI/ASB Standard 121, 1st ed.). American Academy of Forensic Sciences. https://www.aafs.org/sites/default/files/media/documents/121_Std_e1.pdf

Aitken, B., Hayley, A. C., Ford, T. C., Geier, L., Shiferaw, B. A., & Downey, L. A. (2023). Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study. Journal of Psychopharmacology, 37(12), 1227–1237. https://doi.org/10.1177/02698811231200878

Buffett-Jerrott, S. E., & Stewart, S. H. (2002). Cognitive and sedative effects of benzodiazepine use. Current Pharmaceutical Design, 8(1), 45–58. https://doi.org/10.2174/1381612023396654

Curran, H. V. (1991). Benzodiazepines, memory and mood: A review. Psychopharmacology, 105(1), 1–8. https://doi.org/10.1007/BF02316856

Djezzar, S., Gaulier, J. M., Gorgiard, C., Chèze, M., Alvarez, J. C., Martin, C., Dumestre-Toulet, V., Lavit, M., Mathieu, O., Eysseric, H., Berland, E., Roussel, C., Gaillard, Y., Hurtel-Lemaire, A. S., Deveaux, M., & Pion, C. (2023). Assessment of 19 years of a prospective national survey on drug-facilitated crimes in France. Legal Medicine, 65, Article 102297. https://doi.org/10.1016/j.legalmed.2023.102297

Fiorentin, T. R., & Logan, B. K. (2019). Toxicological findings in 1000 cases of suspected drug facilitated sexual assault in the United States. Journal of Forensic and Legal Medicine, 61, 56–64. https://doi.org/10.1016/j.jflm.2018.11.006

Garriott, J. C., & Manno, J. E. (2008). Pharmacology and toxicology of ethyl alcohol. In J. C. Garriott (Ed.), Garriott’s medicolegal aspects of alcohol (5th ed., pp. 25–45). Lawyers & Judges Publishing.

Ghoneim, M. M., & Mewaldt, S. P. (1990). Benzodiazepines and human memory: A review. Anesthesiology, 72(5), 926–938. https://doi.org/10.1097/00000542-199005000-00024

Hartzler, B., & Fromme, K. (2003b). Fragmentary and en bloc blackouts: Similarity and distinction among episodes of alcohol-induced memory loss. Journal of Studies on Alcohol, 64(4), 547–550. https://doi.org/10.15288/jsa.2003.64.547

Joint Service Committee on Military Justice. (2025). Amendments to the Military Rules of Evidence since 1984 (G. E. Maggs, Ed.; 2025 ed.). https://jsc.defense.gov/Portals/99/MRE%20Amendments%202025.pdf

Kleykamp, B. A., Griffiths, R. R., & Mintzer, M. Z. (2010). Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Experimental and Clinical Psychopharmacology, 18(1), 1–16. https://doi.org/10.1037/a0018407

Nutt, D. J., Besson, M., Wilson, S. J., Dawson, G. R., & Lingford-Hughes, A. R. (2007). Blockade of alcohol’s amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology, 53(7), 810–820. https://doi.org/10.1016/j.neuropharm.2007.08.008

Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72(2), 136–142. https://doi.org/10.1001/jamapsychiatry.2014.1763

Pérez Orts, M., van Asten, A., & Kohler, I. (2023). The evolution toward designer benzodiazepines in drug-facilitated sexual assault cases. Journal of Analytical Toxicology, 47(1), 1–25. https://doi.org/10.1093/jat/bkac017

Roth, T., Roehrs, T., Wittig, R., & Zorick, F. (1984). Benzodiazepines and memory. British Journal of Clinical Pharmacology, 18(Suppl. 1), 45S–49S. https://doi.org/10.1111/j.1365-2125.1984.tb02581.x

Saum, C. A., & Inciardi, J. A. (1997). Rohypnol misuse in the United States. Substance Use & Misuse, 32(6), 723–731. https://doi.org/10.3109/10826089709039372

Soo-ampon, S., Wongwitdecha, N., Plasen, S., Hindmarch, I., & Boyle, J. (2004). Effects of word frequency on recall memory following lorazepam, alcohol, and lorazepam alcohol interaction in healthy volunteers. Psychopharmacology, 176(3–4), 420–425. https://doi.org/10.1007/s00213-004-1888-5

Tanaka, E. (2002). Toxicological interactions between alcohol and benzodiazepines. Journal of Toxicology: Clinical Toxicology, 40(1), 69–75. https://doi.org/10.1081/CLT-120002887

Viatris Specialty. (2024). Xanax (alprazolam) tablets [Package insert]. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb5cf72e-3a41-41a8-9a38-80f974eca33f

White, A. M., Simson, P. E., & Best, P. J. (1997). Comparison between the effects of ethanol and diazepam on spatial working memory in the rat. Psychopharmacology, 133(3), 256–261. https://doi.org/10.1007/s002130050399

Legal Authorities

Dep’t of the Army, Pam. 27-9, Military Judges’ Benchbook (July 29, 2025), Instructions 5-21 (voluntary intoxication), 6-4 and 6-7 (lack of mental responsibility).

United States v. Rice, No. ACM 39071 (reh) (A.F. Ct. Crim. App. Jan. 29, 2021) (unpublished).

Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993).

Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999).

State v. Lindsey, 149 Ariz. 472, 720 P.2d 73 (1986).

State v. McKeon, 201 Ariz. 571 (App. 2002).

United States v. Hensler, 44 M.J. 184 (C.A.A.F. 1996).

United States v. Houser, 36 M.J. 392 (C.M.A. 1993).

United States v. MacDonald, 73 M.J. 426 (C.A.A.F. 2014).

10 U.S.C. § 920 (Article 120, Uniform Code of Military Justice).

18 U.S.C. § 2241(b)(2).

Ariz. Rev. Stat. Ann. § 13-503.

Ariz. Rev. Stat. Ann. § 13-1401.

Ariz. Rev. Stat. Ann. § 13-1406(B).

Fed. R. Evid. 702.

Mil. R. Evid. 702.

Ariz. R. Evid. 702.

Ariz. Sup. Ct. Order R-23-0004 (amending Ariz. R. Evid. 702, effective Jan. 1, 2024).

Rule for Courts-Martial 916(l)(2).

Revised Arizona Jury Instructions (Criminal), Standard Criminal 39.

Related topic papers: Medications That Add to Alcohol’s Effects · The Hippocampus and Memory Formation During a Blackout · Fragmentary and En Bloc Blackouts · Alcohol, Cannabis, and Blackouts · Causes of Blackouts: Drinking Pattern and Individual Risk Factors

Related topics from Arizona Forensic Services: Counterintuitive Testimony: Drug-Facilitated Sexual Assault: Toxicology, Detection Limits, and What the Results Can Show · Memory in the Courtroom: Intoxication and Memory